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Abstract: DNA-based nanostructures have received great attention as molecular vehicles 
for cellular delivery of biomolecules and cancer drugs. Here, we report on the cellular 
uptake of tubule-like DNA tile-assembled nanostructures 27 nm in length and 8 nm in 
diameter that carry siRNA molecules, folic acid and fluorescent dyes. In our observations, 
the DNA structures are delivered to the endosome and do not reach the cytosol of  
the GFP-expressing HeLa cells that were used in the experiments. Consistent with this 
observation, no elevated silencing of the GFP gene could be detected. Furthermore, the 
presence of up to six molecules of folic acid on the carrier surface did not alter the uptake 
behavior and gene silencing. We further observed several challenges that have to be 
considered when performing in vitro and in vivo experiments with DNA structures:  
(i) DNA tile tubes consisting of 42 nt-long oligonucleotides and carrying single- or  
double-stranded extensions degrade within one hour in cell medium at 37 °C, while the 
same tubes without extensions are stable for up to eight hours. The degradation is caused 
mainly by the low concentration of divalent ions in the media. The lifetime in cell medium 
can be increased drastically by employing DNA tiles that are 84 nt long. (ii) Dyes may get 
cleaved from the oligonucleotides and then accumulate inside the cell close to the 
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mitochondria, which can lead to misinterpretation of data generated by flow cytometry and 
fluorescence microscopy. (iii) Single-stranded DNA carrying fluorescent dyes are 
internalized at similar levels as the DNA tile-assembled tubes used here. 
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1. Introduction 
Therapeutic agents must overcome multiple barriers to reach their target [1,2]. For example, 
siRNAs have to reach the target tissue, enter the cells, be released from the endosomal compartment 
and, finally, silence the target gene via the RISC complex [3]. Up to now, researchers have developed 
a variety of nanoparticle carrier systems to overcome these barriers, such as polymers [4],  
liposomes [5] or conjugates [6], with various levels of efficiency and toxicity. Most recently, with 
improvements in the DNA nanotechnology field, DNA-based nanostructures were developed as carrier 
systems for a variety of active components, including siRNAs [7], antibodies [8], immunostimulants [9,10] 
and cancer drugs [11,12]. DNA nanostructures are promising for delivery applications because they 
can be easily modified with a variety of (bio)chemical moieties for targeting purposes at nanoscale 
precision; they are monodisperse with well-defined sizes and are non-cytotoxic [10,13–18]. To date, 
several groups have investigated the targeted delivery of DNA-based nanostructures using different 
targeting agents, such as cell penetrating peptides or small molecules. Among them, folate is a 
commonly-used molecule, due to the high expression of its receptors on certain cancer cells. Efficient 
folate-mediated uptake has been demonstrated using various DNA-based structures, such as DNA 
nanotubes built from a single palindromic DNA strand [19] or Y-shaped DNA nanostructures prepared 
by rolling circle amplification [20]. Although the DNA-based nanostructures are promising for 
targeted delivery applications, as exemplified above, the stability of these structures at 37 °C in blood 
or tissue is one of the main issues to be considered. In a recent study, the stability of a variety of DNA 
origami structures with different designs, such as octahedron, six-helix bundle tubes or 24-helix bundle 
rods, were investigated using in vitro conditions, and time-and shape-dependent denaturation and 
digestion were observed due to the Mg2+ depletion in the media and the DNase activity of the  
serum [21]. As an alternative to the DNA origami method [14,15] and shape-specific designs, such as 
DNA cubes [22], tetrahedrons [23] or octahedrons [24], single-stranded tile assembly has recently 
proven to be a versatile and modular design strategy to build a wide variety of two- and  
three-dimensional shapes [25,26]. In this study, we intended to show efficient folate-mediated uptake 
and subsequent gene silencing by tile-assembled DNA nanotubes carrying GFP siRNAs in vitro. 
However, we were not able to demonstrate the sought-after effects, but instead observed untimely 
disassembly of our constructs under certain in vitro conditions and, therefore, investigated strategies to 
maintain the structural integrity in relevant environments. We examined the stability of tile-assembled 
structures under limited divalent cations and in the presence of nucleases in buffer and in cell media. 
We then describe a number of artifacts that should be taken into consideration during experiments with 
DNA-based nanostructures in vitro. 
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2. Results and Discussion 
2.1. Design and Self-Assembly of Six-Helix DNA Nanotubes 
We designed tubule-like DNA nanostructures consisting of 24 oligonucleotides that self-assemble 
into six parallel helices using the single-stranded DNA tile assembly method introduced by Yin et al. 
(Scheme 1 and Table S1) [25,27]. Six of the oligonucleotides were alkyne-modified during synthesis 
and conjugated in-house with PEG-folate-azide (Baseclick GmbH, Tutzing, Germany) by a click 
reaction. Reversed phase high performance chromatography (RP-HPLC) analysis and matrix-assisted 
laser desorption/ionization (MALDI) mass spectrometry revealed the almost quantitatively conjugation 
of folate molecules to the alkyne-oligonucleotides. (Figures S1 and S2, Table S2). Another set of six 
oligonucleotides was extended by an 18 nt-long sequence at the 3' end to allow the attachment via 
hybridization of six siRNA molecules that potentially silence the expression of GFP upon delivery. To 
visualize the DNA nanotubes in vitro, two different labeling strategies were employed. In the first 
approach, Atto488-dUTP was enzymatically labeled to the 3' end of a set of 12 tile oligonucleotides 
using terminal transferase. In the second approach, the same set of oligonucleotides was extended with 
another 18 nt-long sequence allowing attachment via hybridization of 12 Atto647-modified (via NHS 
chemistry) oligonucleotides. The nanotubes have a designed length of ~27 nm and an expected 
diameter of ~6 nm for the dried sample. Note that the tube diameter of a six-helix bundle increases in 
buffer to 8 nm and that tubes decorated with additional molecules will have a larger effective  
diameter [28]. 
 
Scheme 1. DNA nanotube assembly. (Left) Click reaction of alkyne-modified 
oligonucleotides with azide-modified PEGylated folate. (Right) Self-assembly of 24 
oligonucleotides into a six-helix tube after a 17-h annealing process. 
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The nanotube structures containing the desired subsets of oligonucleotides and modifications were 
folded in TE-buffer containing 20 mM Mg2+ during a thermal annealing process starting at 80 °C and 
cooling down to room temperature over the course of 17 h. Analysis by gel electrophoresis analysis 
showed for all designs prominent bands representing the folded structures (Lanes 2 + 3 + 4 in  
Figure 1). Conjugation of folate and folate + siRNA (Lanes 3 and 4, respectively) to the DNA 
nanotubes leads to a decrease of their mobility in comparison to nanotubes without folate and siRNA 
(Lane 2). Transmission electron microscopy (TEM) demonstrates the correct assembly of the 
nanotubes and the monodispersity of the samples. The measured length of 27 ± 1 nm and the measured 
diameter of 6 ± 1 nm perfectly match the expected dimensions (Figure 1B–D). 
 
Figure 1. Characterization of nanotubes. (a) Gel electrophoresis analysis of assembled 
nanotubes: (1) 1-kb ladder, (2) nanotube, (3) nanotube + folate, (4) nanotube + folate + 
siRNA, and (5) individual oligonucleotide. Electron micrographs of (b) Nanotubes;  
(c) Nanotubes with folate; and (d) Nanotubes with folate and siRNA (scale bars: 50 nm; 
insets: 20 nm). 
2.2. Tubule-Like Tile-Assembled DNA Nanostructures Are Delivered to the Endosome of HeLa Cells 
Independently of Folic Acid and Are Not Capable of Releasing siRNA into the Cytosol 
DNA nanotubes labeled with Atto488 via enzymatic labeling were added to HeLa cell cultures at  
10 nM, together with dextran-AF647 as a marker for endosomal uptake. At various time points 
thereafter, confocal microscopy was performed to evaluate the localization of the construct. After 24 h, 
we found clear co-localization of the nanotubes with dextran (Figure 2A–C). Observations for up to  
72 h did not show any change in localization (Figure S3C,D). 
To determine a potential effect of uptake via the folate receptor, which is highly expressed on the 
surface of HeLa cells, nanotubes with and without folic acid were compared side by side. No influence 
on the endosomal staining pattern was noticed in the fluorescence microscopy images, neither after  
24 h nor after 72 h (Figure S3). For a quantitative analysis of the uptake, we conducted flow 
cytometry-based measurements of the HeLa cells at different time points after the addition of 
fluorophore-labeled nanotubes (Figure 2D). A minor signal was already detected after 4 h, which 
further increased in the course of 24 h. No significant difference was found between the uptake of 
nanotubes with or without folate. 
On a functional level, we tested if the nanostructures released their siRNA cargo successfully to the 
cytoplasm by analyzing the knockdown capacity of siRNA molecules bound to the DNA nanotube. 
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Stably GFP-transfected HeLa cell lines were used together with siRNA directed against GFP (siGFP). 
The siGFP was either bound to the nanostructure via hybridization or transfected into the cytoplasm by 
lipofection as a positive control. The GFP signal of the cells was measured by flow cytometry after  
96 h (Figure 2E). In the condition with lipofection of GFP-targeting siRNAs, the fluorochrome signal 
was markedly decreased compared to lipofection of a control siRNA (siCTRL). However, the addition 
of siGFP to the nanotubes did not result in GFP-knockdown, independent of folate labeling, consistent 
with endosomal trapping of the whole structure, including their siRNA cargo. 
 
Figure 2. Endosomal uptake of nanotubes in HeLa cells. Endosomal staining of nanotubes 
with dextran. (a) Nanotubes; (b) Dextran; (c) Merged image from (a), (b) and a third 
channel (DAPI, blue). (d) Flow cytometry analysis of folate-dependent uptake of  
Atto488-labeled nanotubes over 24 h. Untreated cells act as the control, and the specific 
fluorescence intensity (SFI) of the dye is depicted. (e) Fluorescence intensity of stably 
GFP-expressing Hela cells upon the addition of nanotubes carrying GFP-targeting siRNAs 
or upon transfection of a GFP-targeting siRNA and a non-targeting siRNA, respectively, as 
controls using lipofection (LF). The median fluorescence intensity (MFI) of GFP is depicted. 
2.3. Stability of DNA Nanotubes Differs in Various Conditions In Vitro 
To address the stability of tile-assembled DNA nanostructures in vitro, we incubated them in 
different buffers and cell media. First, we incubated the nanotubes in PBS with different Mg2+ 
concentrations at 37 °C for 2 h. We used PBS as a buffer to simulate the cell media conditions, as both 
cell media and PBS possess several monovalent and divalent cations at isotonic concentrations. 
Importantly, for the assembly and stabilization of the DNA nanostructures, usually Mg2+ concentrations 
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much higher than those found in PBS and cell media are used. While folding of DNA nanostructures 
can also be achieved at high Na+ concentrations [29], the 135 mM NaCl present in PBS are not 
sufficient to stabilize DNA nanotubes at 37 °C, if the individual DNA tiles are 42 nt long. Gel analysis 
revealed that the nanotubes without extensions were stable down to 1 mM Mg2+, whereas the 
nanotubes carrying siRNA started to degrade already below 4 mM Mg2+ (Figure 3A,B). This indicates 
that the addition of extension sequences protruding from the DNA nanotubes destabilizes the structure, 
which may be explained by distorted stacking of the last base before the extension and with an increase 
of electrostatic repulsion between the elongated tail and the DNA duplexes in the nanotube [30]. Next, 
we compared the stability of nanotubes against DNases and incubated the structures in cell medium 
containing 10% FCS. Gel analysis showed that under these conditions, the plain nanotubes are stable 
up to 8 h (Figure 3C). However, nanotubes carrying siRNA were degraded in 1 h when the structures 
were incubated in media containing 10% FCS. These nanotubes were also degraded slightly during 8 h 
in DMEM medium without FCS, likely due to Mg2+ depletion (in all cell media experiments, the 
concentration of Mg2+ was 1.8 mM). 
 
Figure 3. Stability of nanotubes. (a) Stability of nanotubes in PBS with different Mg2+ 
concentrations; (b) Stability of nanotubes carrying siRNA in PBS with different Mg2+ 
concentrations; (c) Stability of nanotubes in DMEM medium in the absence or presence of 
FCS; (d) Stability of nanotubes carrying siRNA in DMEM medium in the absence or 
presence of FCS (L: 1 kb ladder; C: control. All samples were incubated at 37 °C). 
To overcome the problem of premature degradation, DNA tile tubes were assembled from  
84 nt-long oligonucleotides. This design allows longer complementary regions (21 bp for the 84mers 
instead of 10 bp and 11 bp for the 42mers) within the tile assembly, which, in turn, yields much higher 
thermal stability, but also higher resistance to Mg2+ depletion (Figure 4). Our results show that the 
stability of tile-assembled nanotubes is dependent on sequence design, temperature, salt concentration 
and structural modifications, such as the addition of single- or double-stranded extensions to the  
DNA tiles. 
  




Figure 4. Stability of nanotubes assembled from 84 nt-long oligonucleotides.  
(a) Schematic depiction of a section of the 6HT demonstrating the hybridization of 84mers; 
(b) Schematic depiction of a section of the 6HT demonstrating the hybridization of 42mers; 
(c) Stability of nanotubes (84mers) in PBS with different Mg2+ concentrations; (d) Stability 
of nanotubes (84mers and 42mers) in DMEM + 10% FCS, DMEM and PBS. Nanotubes 
were incubated at 45 °C for 2 h (L: 1 kb ladder; C: control). 
2.4. Strong Extra-Endosomal Uptake Can Be Feigned by Dye Cleavage 
When nanostructures labeled with Atto647 via hybridization were incubated with HeLa cells, we 
repeatedly observed a very high fluorescence level in the cells during microscopy- or flow  
cytometry-based analysis. Furthermore, the fluorochrome did not co-localize with dextran as an 
endosomal marker (Figure 5A), but instead, mitochondrial localization was detected (Figure 5B). The 
level of uptake and the mitochondrial staining pattern were associated with the addition of serum to the 
culture medium (Figure S4). Similarly, when only the oligonucleotide labeled with Atto647 (via NHS 
chemistry) was added to the HeLa cells, we observed a rapid and strong staining of the cells only in the 
case when serum was added (Figure 5C). This effect was not observed when the fluorophores were 
attached via enzymatic binding. We therefore conclude that Atto647 is cleaved off the DNA by some 
component in the serum and is taken up independently of the nanostructure. 
2.5. Single-Stranded DNA Molecules, But Not Deoxynucleotide Triphosphates, Are Internalized at 
Similar Levels as the Tile-Assembled Nanotube Structures 
Specific uptake of the tubule-like tile-assembled DNA nanostructures was analyzed by direct 
comparison with oligonucleotides and deoxynucleotide triphosphates. All three molecules were labeled 
with Atto488 and incubated at identical molar concentrations with HeLa cells. Fluorochrome uptake 
was measured by flow cytometry at various time points (Figure 5D). No intracellular staining was 
found in the deoxynucleotide triphosphate condition. However, we observed similar uptake of the 
fluorochrome with the oligonucleotide as with the nanostructure. 




Figure 5. Effect of dye cleavage on cellular uptake. (a) Endosomal staining using Alexa 
Fluor 488-coupled dextran (shown in green) of HeLa cells treated with 
oligodeoxynucleotide (ODN)-Atto647 (shown in red); (b) Mitochondrial colocalization of 
Atto647 (shown in red) in HeLa cells stained with the mitochondrial dye MitoTracker 
Green (shown in green). Nuclei are stained with Hoechst 33342; (c) Flow cytometry 
analysis of fluorescence intensity of cells treated with ODN-Atto647 in the absence or 
presence of FCS; (d) Flow cytometry analysis of fluorescence intensity of cells treated 
with Atto488-dUTP, ODN-Atto488 and nanotube labeled with Atto488. Untreated cells act 
as the control, and the specific fluorescence intensity (SFI) of the dye is depicted. 
3. Experimental Section 
3.1. DNA Nanotube Design 
DNA nanotubes were designed using Yin’s single-strand tile (SST) method [27]. Each tile 
oligonucleotide is 42 bases long and consists of four domains with ten or eleven bases. Twenty four 
individual oligonucleotides were used to form 6 helix nanotube. The domains at the ends of the 
nanotube contain non-pairing poly-A sequences to prevent polymerization. siRNA hybridization to the 
nanotubes was done by extending 3' ends of six tiles with an 18-nt long overhang sequence  
(5'-AGGATGTAGGTGGTAGAG-3'). The used siRNA sequences for GFP silencing were sense:  
5'-GCCACAACGUCUAUAUCAU-3', and antisense: 5'-AUGAUAUAGACGUUGUGGC 
CTCTACCACCTACATCCT-3'. Six oligonucleotides were modified with PEG-folate azide (Baseclick 
GmbH, Tutzing, Germany) using click reactions. The underlined sequence shows the complementary 
overhang. All oligonucleotides were purchased from Eurofins (Ebersberg, Germany) with HPSF or 
HPLC purification. 
  
Nanomaterials 2015, 5 55 
 
 
3.2. Folate Conjugation and Characterization of Oligonucleotides 
Each of the six alkyne-modified oligonucleotides (Baseclick GmbH) were submitted to click 
reaction, using CuBr as the Cu(I) source. Ten microliters of a freshly prepared CuBr (0.1 M)/THPTA 
(0.1 M) solution in a 1:2 v/v ratio were added to a 50-µL (0.1 mM, 5 nmol) solution of each  
alkyne-oligonucleotide. The addition of folate-PEG3-azide (2.5 µL, 10 mM in DMSO) completed the 
click reaction cocktail. The mixture was mixed for 1.5 h at 45 °C. Finally, the solution was purified via 
ethanol precipitation. Folate-conjugated oligonucleotides were analyzed by analytical RP-HPLC 
(e2695 system, Waters, Milford, MA, USA) coupled with a photodiode array detector (PDA 2998, 
Waters) using a reversed phase XBridge OST C18 column (4.6 mm × 50 mm, Waters). Before 
injection in RP-HPLC, samples were diluted to 10 µM concentration in HPLC-grade H2O. Samples  
(2 µL) were desalted against ddH2O using a nitrocellulose membrane (MerckMillipore, Frankfurt, 
Germany), and 0.4 µL were spotted onto a MALDI plate (Bruker Corporation, Millerica, MA, USA) 
along with 0.4 µL of 3-hydroxypicolinic acid (HPA, Sigma Aldrich, St. Luis, MO, USA). Measurements 
were carried out with the Autoflex MALDI-TOF (Bruker Corporation). 
3.3. Dye Labeling of DNA Nanotubes 
Fluorescent dyes were conjugated to the 12 oligonucleotides with two different approaches before 
the nanotube assembly. In the first approach, 3' ends of twelve tiles were extended by 18 nt-long 
overhang sequences to hybridize the dye-modified sequence: (Atto647 TTCATTCTCCTATTACTACC). 
In the second approach, the 3' ends of the same tiles were enzymatically labeled with Atto488-dUTP 
(Jena Bioscience, Jena, Germany). For this, Atto488-dUTP (80 µM), CoCl2 (5 mM), terminal 
transferase enzyme (16 U/µL, Roche, Penzberg, Germany) and all DNA tiles (400 pmol) were mixed 
in a 20 µL, 1× TdT reaction buffer and then incubated at 37 °C for 30 min. Then, 2.5 µL of NaOAc  
(3 M) were added, and the solution was filled up to 80 µL with ice-cooled ethanol (99%). After 1 h of 
incubation at −20 °C, samples were centrifuged at 13,000× g for 30 min. Then, samples were washed 
with 70% ethanol for 10 min again, and the supernatant was discarded. The remaining pellet was 
dissolved in distilled water. 
3.4. DNA Nanotube Assembly and Purification 
For DNA nanotube assembly, 400 nM of dye and folate modified tiles, 800 nM of antisense-ODN 
and 1.6 µM of sense-ODN were mixed in a folding buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0,  
20 mM MgCl2). For the plain nanotube assembly, 1 µM of unmodified tiles was used. The DNA 
nanotubes were folded over the course of 16 h (5 min at 80 °C, cooling down to 65 °C at 1 °C/min, 
cooling down to 25 °C at 2.5 °C/h). Purification of the assembled DNA nanotubes was done using 30K 
Amicon Ultra 0.5-mL centrifuge filters (30000 MWCO, Millipore, Schwalbach, Germany) to remove 
excess strands that were not folded into the structures. One hundred microliters of assembled DNA 
nanotube solution were mixed with 400 µL of folding buffer, filled into the centrifuge filter, and 
centrifuged 3 times at 13,000× g for 6 min. After every centrifuge step, the flow-through was removed 
and the filter was refilled up to 500 µL with buffer. After final centrifugation, the remaining solution at 
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the bottom of the filter (~50 µL) was pipetted out, and the concentration of nanotubes was determined 
by measuring the optical density at 260 nm. 
3.5. Gel Electrophoresis and Transmission Electron Microscopy 
DNA nanotubes were analyzed by running samples in an agarose gel. For this, 2% agarose was 
dissolved in 0.5× TAE buffer by heating to boiling. MgCl2 (11 mM) and ethidium bromide  
(0.5 µg/mL) were added after the cooling, and the solution was poured into a gel cask for solidification. 
Twenty microliters of each filter-purified DNA nanotube sample were mixed with 4 µL of 6× loading 
dye before loading into the gel pockets. Six microliters of 1 kb ladder were also loaded adjacent to the 
samples. The gel was run for 2 h at 70 V in an ice-cold water bath to prevent heat-induced denaturation 
of DNA nanotubes. To visualize DNA nanotubes, a JEM-1011 transmission electron microscope 
(JEOL GmbH, Eching, Germany) was used. DNA nanotubes were incubated on plasma-exposed  
(240 kV for 1 min) carbon-coated grids and then negatively stained with 2% uranyl formate for 10 s. 
3.6. Stability of DNA Nanotubes 
The stability of DNA nanotubes was tested in PBS buffer, DMEM and DMEM containing 10% 
FCS, separately. One microliter of DNA nanotubes (50 ng/µL) in 20 µL of buffer/medium was 
incubated at 37 °C for different time points. Two percent agarose gel with 11 mM MgCl2 was prepared 
to analyze the samples, as mentioned in Experimental Section 3.5. 
3.7. Cell Culture Experiments 
HeLa cells were cultured at 37 °C, 5% CO2 and 95% humidity in Dulbecco’s modified Eagle’s 
medium (Life Technologies Thermo Fischer, Waltham, MA, USA) supplemented with 10%  
heat-inactivated fetal calf serum (FCS, Invitrogen Thermo Fischer, Waltham, MA, USA), 2 mM  
L-glutamine, 100 U/mL penicillin and 100 µg/mL streptomycin. Stably GFP-transfected HeLa cell 
lines were generated by retroviral transduction using an eGFP containing pMP71 vector, as described 
previously [31,32]. To analyze uptake, DNA nanotubes, oligonucleotides and deoxynucleotide 
triphosphates were added to HeLa cells at a concentration between 10 and 40 nM for the indicated 
period of time in DMEM with L-glutamine, penicillin, streptomycin and either supplemented or not 
with 10% FCS. For siRNA-mediated knockdown experiments, GFP-expressing HeLa cells were 
seeded in 24-well plates and allowed to adhere overnight. On the next day, cells were either incubated 
with the indicated nanotubes coupled to GFP-targeting siRNAs or were transfected as a control with 
siRNA oligonucleotides (75 nM) using Lipofectamine RNAiMAX (Invitrogen). After 48 h,  
GFP-knockdown was measured by flow cytometry. The siRNA sequence used to target GFP (siGFP) 
was 5' GCCACAACGUCUAUAUCAU 3'. As a control (siCTRL), we used the non-targeting RNA 
sequence 5' GCGCUAUCCAGCUUACGUA 3' described previously [33]. SiRNAs were purchased 
from Eurofins and contained dTdT overhangs. 
  
Nanomaterials 2015, 5 57 
 
 
3.8. Flow Cytometry and Confocal Fluorescence Microscopy 
Flow cytometry was used to determine the uptake of DNA nanotubes, oligonucleotides and 
deoxynucleotide triphosphates labeled with the fluorescent dyes, Atto488 or Atto647, into HeLa cells 
and to assess the knockdown efficiency of GFP-targeting siRNAs in stably GFP-expressing HeLa cells. 
For that, after the indicated time points, single-cell suspensions were prepared and washed several 
times before analyzing the cells on a FACS Calibur (Becton Dickinson, Franklin Lakes, NJ, USA). 
FlowJo software was used to analyze the data. GFP expression was depicted by median fluorescence 
intensity (MFI). For all experiments with fluorescent dye labeling, the data are represented as specific 
fluorescence intensity (SFI), which was calculated by dividing the MFI of the sample by the MFI of 
the control. Confocal fluorescence microscopy was used to determine the subcellular localization of 
nanotubes and RNAs taken up by HeLa cells. For that, HeLa cells were cultured in CELLview cell 
culture dishes with a glass bottom (Greiner Bio One). After incubation with Atto488- or  
Atto647-labeled nanotubes for the indicated time points, cells were washed three times with PBS and 
used for live-imaging on a Leica TCS SP5 confocal microscope (Leica Microsystems GmbH, Wetzlar, 
Germany). Zero-point-two micrograms per milliliter of Hoechst 33342 and MitoTracker Green (both 
from Life Technologies) were used according to the manufacturer’s protocol to stain nuclei and 
mitochondria, respectively. In order to visualize endosomes, 20 µg/mL dextran labeled with Alexa 
Fluor 647 or Alexa Fluor 488 (Life Technologies Thermo Fischer) were added simultaneously with the 
DNA nanotubes. 
4. Conclusions 
In this study, we investigated the cellular delivery of tile-assembled DNA nanotubes carrying 
siRNAs using GFP-expressing HeLa cells via folate targeting. We observed that the nanostructures 
enter the cells via an endosomal pathway, but the nanostructures and their siRNA cargo are not capable 
of reaching the cytoplasm for knockdown and gene silencing. Contingently, no significant decrease in 
GFP expression levels was detectable, and folate modification did not change the uptake kinetics. The 
stability experiments revealed that unmodified DNA nanotubes are stable at 37 °C up to 8 h in the cell 
media and that they stay intact in PBS buffer containing 2 mM Mg2+ or more. However, the extension 
of the DNA tile strands with sequences that allow the hybridization of siRNA or dye-modified strands 
drastically decreases the construct’s stability, a fact that may have contributed to the unsuccessful 
folate targeting experiments. Using DNA tiles that were 84-nt long drastically increased the stability in 
all cell media and buffers with low Mg2+ concentrations. Importantly, we observed that DNA strands 
alone and cleaved dyes are also uptaken by the cells, which can lead to the misinterpretation of 
recorded data. Overall, the results presented in this study demonstrate the importance of rigorously 
testing the stability of DNA nanostructures before applications in vitro and in vivo. 
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